葡萄王

-2.40 (-2.63%)最後更新 2026-09-11

台灣 · 上市 · 生技醫療業

89.00828成交張數11.48本益比1.29股價淨值比6.74%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	150	102	22.7%	1.59	69.11	11.5%	7.7%	2.8	2.4
2026Q1	155	100	23.5%	1.60	67.44	12.1%	7.8%	3.8	1.7
2025Q4	157	103	23.3%	1.65	69.81	11.9%	7.8%	11.7	10.4
2025Q3	145	102	19.7%	1.80	68.53	12.1%	8.5%	1.6	0.5
2025Q2	149	98	25.3%	1.47	66.19	13.8%	8.9%	8.3	7.2
2025Q1	149	97	22.8%	1.64	65.26	14.0%	9.2%	0.1	-0.8
2024Q4	153	101	23.1%	1.68	67.88	14.5%	9.4%	12.1	10.6
2024Q3	144	100	20.0%	1.73	67.64	15.0%	10.3%	4.6	2.8
2024Q2	150	96	27.7%	1.36	64.64	15.2%	9.3%	0.9	-0.5
2024Q1	156	103	22.8%	1.83	69.26	14.2%	9.3%	1.1	-0.3
2023Q4	155	100	25.0%	1.66	67.36	14.9%	9.5%	16.5	14.2
2023Q3	141	95	22.2%	1.65	64.36	15.6%	10.5%	-2.2	-3.2
2023Q2	154	91	32.7%	1.27	61.64	16.3%	9.7%	10.1	9.1
2023Q1	151	99	23.4%	1.76	66.53	15.7%	10.3%	0.8	-0.7
2022Q4	151	96	26.0%	1.56	64.60	15.7%	10.0%	17.0	15.2
2022Q3	137	91	23.7%	1.50	61.47	16.2%	10.7%	-0.1	-1.5
2022Q2	145	87	31.9%	1.25	58.94	15.2%	9.7%	12.1	11.4
2022Q1	140	93	22.7%	1.68	62.54	14.4%	9.5%	1.0	0.0
2021Q4	141	90	25.8%	1.51	60.68	16.7%	9.6%	13.7	13.2
2021Q3	129	85	24.4%	1.42	57.64	17.4%	10.3%	3.9	2.8
2021Q2	136	92	24.4%	1.57	62.00	17.1%	10.2%	6.8	6.2
2021Q1	134	89	23.0%	1.64	59.84	16.3%	9.9%	1.0	0.5
2020Q4	131	66	39.1%	1.13	48.61	19.9%	10.4%	14.2	13.7
2020Q3	120	62	38.9%	0.93	45.35	21.4%	11.4%	3.6	2.7
2020Q2	117	58	42.0%	0.71	42.66	22.8%	11.5%	7.9	0.0
2020Q1	116	64	32.5%	1.16	47.14	21.1%	11.6%	1.5	-1.4
2019Q4	114	62	34.2%	1.09	45.30	22.0%	11.9%	12.1	11.5
2019Q3	105	58	34.9%	0.92	42.22	23.3%	12.7%	2.9	1.2
2019Q2	105	54	39.5%	0.63	39.85	25.5%	12.8%	5.3	4.6
2019Q1	110	60	33.4%	0.90	44.13	22.5%	12.3%	1.4	-1.9
2018Q4	106	57	34.9%	0.88	42.05	23.7%	12.6%	11.8	9.2
2018Q3	98	53	35.3%	0.77	38.97	26.4%	14.1%	8.4	4.6
2018Q2	101	49	42.8%	0.73	36.26	28.3%	13.3%	2.6	1.3
2018Q1	100	55	32.6%	1.09	40.67	25.9%	13.8%	1.4	-2.1
2017Q4	99	52	36.0%	1.00	38.42	27.0%	13.9%	12.1	10.6
2017Q3	91	48	37.2%	0.90	35.16	28.8%	14.5%	6.3	3.8
2017Q2	97	44	46.4%	0.89	32.69	33.5%	13.7%	2.0	0.8
2017Q1	95	50	36.6%	1.30	36.62	29.2%	13.7%	4.5	2.0
2016Q4	95	48	39.4%	1.20	35.56	–	–	10.3	8.5
2016Q3	88	42	42.8%	1.01	31.54	–	–	7.3	5.7